Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and cl...
The Fringes of Wall Street: How Small-Cap Innovators and Niche Bets Are Navigating 2026
The Quiet AI Takeover of the Mundane Economy
Certara files Form 3 for interim CFO Mohammed Faiz initial beneficial ownership statement
Certara to report Q2 2026 results, host conference call
17:39 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program | SILO Stock News